Researchers from the University of Iowa may have discovered a safe new way to manage blood sugar non-invasively. Exposing diabetic mice to a combination of static electric and magnetic fields for a few hours per day normalizes two major hallmarks of type 2 diabetes, according to new findings published Oct. 6 in Cell Metabolism.
“We’ve built a remote control to manage diabetes,” says Calvin Carter, PhD, one of the study’s lead authors and a postdoc in the lab of senior author Val Sheffield, MD, PhD, professor of pediatrics, and of ophthalmology and visual sciences at the UI Carver College of Medicine. “Exposure to electromagnetic fields (EMFs) for relatively short periods reduces blood sugar and normalizes the body’s response to insulin. The effects are long-lasting, opening the possibility of an EMF therapy that can be applied during sleep to manage diabetes all day.”
For more than 20 years, researchers in pharma, biotech, and academia have trusted CST for its proven biological and technical expertise and our success is directly linked to the global communities where we live and work. “As scientists and citizens, we cannot ignore the important connections we have with each other, our local communities, and the planet as a whole,” said John Letcher, Cell Signaling Technology, Senior Vice President of Global Human Resources. “We are flattered to be recognized by the Boston Business Journal for our contributions within the Commonwealth of Massachusetts.”
CST charitable initiatives are part of a broader Corporate Social Responsibility focus that includes commitments to Our Planet, Science Education, Our Employees, Surrounding Communities, and the Arts.
At CST we believe in the power of science to help us meet some of the big challenges ahead. Science is our passion, and our mission is